Results 161 to 170 of about 94,964 (299)

Restoration of a Stuck Leaflet

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Severe aortic regurgitation (AR) for a leaflet malfunction after transcatheter aortic valve implantation (TAVI) is a dreadful complication that can lead even to cardiogenic shock. New valve's design has reduced the rate of paravalvular regurgitation, however central regurgitation is still a challenging complication.
Elisa Tomarelli   +3 more
wiley   +1 more source

Alcaptonuria: A Case Complicated with Valvular Heart Disease and Immunodeficiency.

open access: bronze, 1994
Shunsuke Mori   +8 more
openalex   +2 more sources

Regression of metastatic carcinoid tumor after valvular surgery for carcinoid heart disease [PDF]

open access: bronze, 1997
Daniel Rayson   +2 more
openalex   +1 more source

Hybrid Transcatheter Pulmonary Valve Replacement With SAPIEN S3 Following Right Ventricular Outflow Tract Reduction Using Tricuspid Annuloplasty Rings

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT We describe a novel variation of hybrid TPVR using a tricuspid annuloplasty ring which can be considered for patients with very large RVOT, short pulmonary artery, and limited vascular access and to avoid the risk of cardiopulmonary bypass. The utilization of Carpentier‐Edwards Physio Tricuspid annuloplasty ring can reduce the size of the RVOT
Mann Chandavimol   +4 more
wiley   +1 more source

Valvular Heart Disease Care in Pakistan: Impact of the Multidisciplinary Valve Heart Team. [PDF]

open access: yesJACC Adv
Bhatti S   +13 more
europepmc   +1 more source

Analysis of perioperative ventricular arrhythmias in valvular heart diseases by holter ECG recording.

open access: bronze, 1991
Osamu Shigemitsu   +5 more
openalex   +2 more sources

Pulmonary Hemosiderosis Due to Mitral Valvular Heart Disease [PDF]

open access: green, 1999
Eung Yeop Kim   +3 more
openalex   +1 more source

Complications Leading to Death in Patients Supported by the Impella 5.5: Analysis From the FDA MAUDE Database

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The Impella 5.5 is increasingly being used in patients with cardiogenic shock, but experience with the device remains limited, and severe complications, including death, have been reported. This study aims to investigate causes of Impella 5.5‐related deaths.
Omar Khalil   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy